首页> 外文期刊>International journal of endocrinology >Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review
【24h】

Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review

机译:绝经后妇女冠心病患有II型糖尿病的糖尿病和雌激素替代治疗的影响:叙事综述

获取原文
获取原文并翻译 | 示例
           

摘要

Coronary heart disease is the main cause of death in postmenopausal women (PMW); moreover its mortality exceeds those for breast cancer in women at all ages. Type II diabetes mellitus is a major cardiovascular risk factor and there is some evidence that the risk conferred by diabetes is greater in women than in men. It was established that the deficiency of endogenous estrogens promotes the atherosclerosis process. However, the impact of estrogen replacement therapy (ERT) on cardiovascular prevention remains controversial. Some authors strongly recommend it, whereas others revealed a concerning trend toward harm. This review tries to underlines the different components of cardiovascular risk in diabetic PMW and to define the place of ERT.
机译:冠心病是绝经后妇女死亡的主要原因(PMW); 此外,其死亡率超过了所有年龄段的女性乳腺癌的死亡率。 II型糖尿病是一种主要的心血管危险因素,并且有一些证据表明,女性赋予糖尿病的风险比男性更大。 确定内源性雌激素的缺乏促进动脉粥样硬化过程。 然而,雌激素替代治疗(ERT)对心血管预防的影响仍存在争议。 有些作者强烈推荐它,而其他作者则透露了危害危害的趋势。 该审查试图强调糖尿病PMW中心血管风险的不同组分,并定义ert的位置。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号